Merkel cell carcinoma in collision with squamous cell carcinoma and basal cell carcinoma in a patient on ruxolitinib treatment for myeloproliferative neoplasm

Viviana Barrera-Penagos; Daniela Castellanos-Leguizamón; José Antonio Hakim-Tawil; Juan José Santivañez; Paula A Rodríguez-Urrego; Juan Carlos Hiromi López-Takegami

doi:10.1016/j.jdcr.2024.01.024

Merkel cell carcinoma in collision with squamous cell carcinoma and basal cell carcinoma in a patient on ruxolitinib treatment for myeloproliferative neoplasm

JAAD Case Rep. 2024 Feb 2:45:98-101. doi: 10.1016/j.jdcr.2024.01.024. eCollection 2024 Mar.

Authors

Viviana Barrera-Penagos¹, Daniela Castellanos-Leguizamón¹, José Antonio Hakim-Tawil^{2

3}, Juan José Santivañez², Paula A Rodríguez-Urrego¹, Juan Carlos Hiromi López-Takegami¹

Affiliations

¹ Department of Pathology and Laboratories, Fundación Santa Fe de Bogotá, Bogotá D.C., Colombia.
² Division of Head and Neck Surgery, Fundación Santa Fe de Bogotá, Bogotá D.C., Colombia.
³ School of Medicine, Universidad de los Andes, Bogotá D.C., Colombia.

No abstract available

Keywords: Janus kinase inhibitors; Merkel cell carcinoma; basal cell carcinoma; collision tumor; ruxolitinib; squamous cell carcinoma; synchronous tumor.

Publication types

Case Reports